BIOMERICA'S ULCER TEST APPROVED IN JAPAN
BIOMERICA'S ULCER TEST APPROVED IN JAPAN NEWPORT BEACH, Calif., Sept. 17 /PRNewswire/ -- Biomerica Inc.
(NASDAQ: BMRA) announced that its blood test for ulcer and other gastric ailments, including stomach cancer (H. pylori), has been approved for sale in Japan. The approval came after a year of intensive clinical studies by one of the largest laboratories in Japan using Biomerica's product.
Being the first to introduce the ulcer test in Japan through a large Japanese firm, Biomerica anticipates significant revenue generated for the current fiscal year. Biomerica is a medical company engaged in the development, manufacturing and marketing of advanced medical diagnostic products including home self-testing. -0- 9/17/92 R /CONTACT: Joseph Irani, president of Biomerica, 714-645-2111/ (BMRA) CO: Biomerica Inc. ST: California IN: MTC SU: PDT
JB-KJ -- LA001 -- 0614 09/17/92 11:40 EDT
|Printer friendly Cite/link Email Feedback|
|Date:||Sep 17, 1992|
|Previous Article:||CHEMICAL BANKING $300 MILLION 7.25 PERCENT SUBORDINATED NOTES 'A-' BY FITCH -- FITCH FINANCIAL WIRE --|
|Next Article:||TELETEK ANNOUNCES OPENING OF PURCHASE ESCROW IN ACQUISITION OF INTERSTATE PUBLIC TELEPHONE|